These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 2101707)

  • 1. Candida albicans: local and systemic infections. The hygienist's role.
    Meara JW
    Dentalhygienistnews; 1990; 3(4):1, 9, 16. PubMed ID: 2101707
    [No Abstract]   [Full Text] [Related]  

  • 2. Candida-related denture stomatitis: a pilot study of the efficacy of an amorolfine antifungal varnish.
    Milillo L; Lo Muzio L; Carlino P; Serpico R; Coccia E; Scully C
    Int J Prosthodont; 2005; 18(1):55-9. PubMed ID: 15754893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of candida infections.
    Scott E
    Practitioner; 1990 Mar; 234(1484):232, 234, 236. PubMed ID: 2371211
    [No Abstract]   [Full Text] [Related]  

  • 4. [Item no 87: cutaneous-mucosal bacterial and fungal infections: candida albicans].
    CEDEF
    Ann Dermatol Venereol; 2008 Nov; 135(11 Suppl):F42-8. PubMed ID: 18984227
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV].
    Drobacheff C; Manteaux A; Millon L; Reboux G; Barale T; Laurent R
    Ann Dermatol Venereol; 1996; 123(2):85-9. PubMed ID: 8761757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Improper use of antimycotics in oral diseases].
    Sklavounou-Andrikopoulou A; Drikos G
    Odontostomatol Proodos; 1989 Jun; 43(3):291-7. PubMed ID: 2518056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluconazole and/or hexetidine for management of oral candidiasis associated with denture-induced stomatitis.
    Koray M; Ak G; Kurklu E; Issever H; Tanyeri H; Kulekci G; Guc U
    Oral Dis; 2005 Sep; 11(5):309-13. PubMed ID: 16120118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antifungal drug susceptibility of Candida causing oropharyngeal candidiasis in HIV infected patients].
    Dieng Y; Faye-Niang MA; Ndour-Diop A; Sow PS; Dieng T; Soumare M; Bah IB; Faye O; Diop BM; Gaye O; Ndir O; Diallo S
    Dakar Med; 2001; 46(1):4-7. PubMed ID: 15773146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidiasis at ICAAC.
    Barr D; Smart T
    GMHC Treat Issues; 1995 Oct; 9(10):13. PubMed ID: 11362914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral candidiasis in HIV-infected patients.
    Brawner DL; Hovan AJ
    Curr Top Med Mycol; 1995; 6():113-25. PubMed ID: 8724244
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of oral erosive candidosis in a kidney transplant patient.
    Romano C; Ghilardi A; Carcagnì MR; De Aloe GB
    Mycoses; 2004 Dec; 47(11-12):524-6. PubMed ID: 15601462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral mucosal lesions caused by Candida albicans.
    de Waal H
    SADJ; 2003 Mar; 58(2):76. PubMed ID: 12800271
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sensitivity of Candida strains to polyenic antibiotics in the treatment of oral candidiasis].
    Boĭko GI; Sosnin GP; Adarchenko AA; Moroz GS
    Antibiotiki; 1984 Nov; 29(11):869-72. PubMed ID: 6395795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicinal plants used by Tanzanian traditional healers in the management of Candida infections.
    Runyoro DK; Ngassapa OD; Matee MI; Joseph CC; Moshi MJ
    J Ethnopharmacol; 2006 Jun; 106(2):158-65. PubMed ID: 16458463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An ex-vivo oral mucosa infection model for the evaluation of the topical activity of antifungal agents.
    Ohnemus U; Willers C; Bubenheim M; Horstkotte MA; Houdek P; Fischer F; Schmage P; Moll I; Brandner JM
    Mycoses; 2008 Jan; 51(1):21-9. PubMed ID: 18076591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral candidiasis, switching and antifungal resistance.
    Blignaut E
    SADJ; 2000 Dec; 55(12):694. PubMed ID: 12608245
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
    Maninder J; Usha A
    J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Candida albicans morphogenesis by tumor necrosis factor-alpha and potential for treatment of oral candidiasis.
    Ohta H; Tanimoto T; Taniai M; Taniguchi M; Ariyasu T; Arai S; Ohta T; Fukuda S
    In Vivo; 2007; 21(1):25-32. PubMed ID: 17354610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive use of chlorhexidine in oral candidoses: a review.
    Ellepola AN; Samaranayake LP
    Oral Dis; 2001 Jan; 7(1):11-7. PubMed ID: 11354914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.